ABCC2 and oculocutaneous albinism type 1: The ICER for achieving graft survival without acute graft rejection and/or ATN was at the southeast of the quadrant of the cost-effectiveness plane, reflecting that the current approach was more cost-effective among the ABCC2 -24C>T T variant allele carriers compared to the ABCC2 -24C>T C wildtype allele carriers (Figure 2).